Judisana - Company finances
|
EUR
|
2022
From: 2022-11-10
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 3,500 | 18,835 | 14,632 | 28,172 |
| Profit before tax | 2,500 | 5,396 | 278 | 5,184 |
| Net profit | 2,500 | 5,126 | 264 | 4,873 |
| Equity | 2,550 | 3,795 | 4,059 | 7,902 |
| Liabilities | 0 | 90 | 2,581 | 311 |
| Non-current assets | 1,724 | 792 | 7 | 430 |
| Current assets | 826 | 3,093 | 6,633 | 7,783 |
| Total assets | 2,550 | 3,885 | 6,640 | 8,213 |
|
Taxes paid
|
||||
| STI taxes | - | 511 | 734 | 823 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +438.1% | -22.3% | +92.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 98.0% | 131.9% | 4.0% | 59.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.0% | 135.1% | 6.5% | 61.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 71.4% | 27.2% | 1.8% | 17.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 71.4% | 28.6% | 1.9% | 18.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 0.6 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Judisana - Social security debts
The company had no debts to Sodra
Judisana - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-21 | 2025-06-26 | 14.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Judisana, MB (company code 306174039) is a Small partnership operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €28.2K and net profit of €4.9K, with a profit margin of 17.3%. Revenue increased by 92.5% year on year and by 49.6% over two years, showing a clear recovery after the weaker 2024 result. In 2023, revenue was €18.8K and net profit €5.1K, while in 2024 revenue declined to €14.6K and net profit to €264, before rebounding strongly in 2025. The balance sheet also strengthened: total assets rose to €8.2K from €6.6K in 2024 and €3.9K in 2023, while equity increased to €7.9K. Liabilities remained low at €311 in 2025 after €2.6K in 2024 and €90 in 2023. The equity ratio was 96.2%, debt-to-equity was 0.04, and asset turnover reached 3.43x. Return on equity and return on assets were both strong in 2025. No staff data was provided, so productivity per employee cannot be assessed.